TD Asset Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-12,200
Closed -$1.23M 1446
2014
Q4
$1.23M Sell
12,200
-18,800
-61% -$1.46M ﹤0.01% 900
2014
Q3
$2.06M Buy
31,000
+2,500
+9% +$164K ﹤0.01% 821
2014
Q2
$1.99M Sell
28,500
-700
-2% -$47.6K ﹤0.01% 826
2014
Q1
$2.14M Buy
29,200
+1,000
+4% +$74.6K ﹤0.01% 814
2013
Q4
$1.94M Sell
28,200
-23,200
-45% -$1.5M ﹤0.01% 810
2013
Q3
$3.27M Sell
51,400
-21,600
-30% -$1.31M 0.01% 717
2013
Q2
$3.53M Buy
+73,000
New +$3.59M 0.01% 663

TD Asset Management's CBST Position: Q1 2015 in Review

TD Asset Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 12,200 shares — an estimated $1.23M sold.

TD Asset Management first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $3.53M in Q2 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • TD Asset Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • TD Asset Management sold 12,200 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.23M.
  • TD Asset Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • TD Asset Management's CUBIST PHARMACEUTICALS INC position peaked at $3.53M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on TD Asset Management's 13F filing for Q1 2015, filed 28 Apr 2015.